Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
IRWD | US
0.04
0.94%
Healthcare
Drug Manufacturers-Specialty & Generic
30/06/2024
04/10/2024
4.30
4.31
4.37
4.24
Ironwood Pharmaceuticals Inc. a healthcare company focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States Mexico Japan and China as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300 a GC-C agonist for the treatment of visceral pain conditions including interstitial cystitis/bladder pain syndrome and endometriosis; and CNP-104 an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc. AstraZeneca AB and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia Inc. and changed its name to Ironwood Pharmaceuticals Inc. in April 2008. Ironwood Pharmaceuticals Inc. was incorporated in 1998 and is headquartered in Boston Massachusetts.
View LessLow Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Value Stock (Price to Book < 3)
Strong Operating Margin (> 25%)
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
Weak P/E, and PEG ratio indicator
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
56.4%1 month
66.4%3 months
90.3%6 months
76.8%50.25
12.33
2.59
-1.99
1.62
9.71
2.94
-0.26
120.96M
693.71M
693.71M
-
29.07
-68.50
-12.10
-574.72
5.89
14.08
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.72
Range1M
1.26
Range3M
3.31
Rel. volume
0.43
Price X volume
3.68M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pacira Pharmaceuticals Inc | PCRX | Drug Manufacturers-Specialty & Generic | 16.515 | 761.79M | 6.34% | 10.85 | 73.76% |
Radius Health Inc | RDUS | Drug Manufacturers-Specialty & Generic | 17.9 | 506.39M | -4.48% | n/a | 0.00% |
Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 4.42 | 495.19M | 0.00% | n/a | 117.00% |
Aquestive Therapeutics Inc | AQST | Drug Manufacturers-Specialty & Generic | 4.95 | 450.75M | 3.34% | n/a | -329.45% |
Elite Pharmaceuticals Inc | ELTP | Drug Manufacturers-Specialty & Generic | 0.3933 | 420.15M | -6.31% | 19.50 | 0.00% |
Organogenesis Holdings Inc | ORGO | Drug Manufacturers-Specialty & Generic | 3.08 | 408.33M | 8.07% | n/a | 42.12% |
Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 2.12 | 331.23M | 1.44% | n/a | -471.04% |
Aurora Cannabis Inc | ACB | Drug Manufacturers-Specialty & Generic | 5.5 | 301.75M | 2.42% | n/a | 0.00% |
ESSA Pharma Inc | EPIX | Drug Manufacturers-Specialty & Generic | 6.04 | 267.99M | -0.33% | n/a | 0.27% |
Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 4.92 | 262.25M | 2.71% | n/a | 39.24% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Ennis Inc | EBF | Building Products & Equipment | 24.31 | 631.67M | 2.36% | 15.15 | 2.42% |
ACCO Brands Corporation | ACCO | Building Products & Equipment | 5.25 | 502.94M | -0.19% | n/a | 174.23% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 21.28 | 334.47M | -4.23% | n/a | 286.96% |
Marine Products Corporation | MPX | Recreational Vehicles | 9.47 | 328.78M | 0.21% | 13.24 | 0.00% |
MCBC Holdings Inc | MCFT | Recreational Vehicles | 17.64 | 292.95M | -0.56% | 35.53 | 26.82% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
Unifi Inc | UFI | Textile Manufacturing | 6.74 | 123.04M | -2.46% | n/a | 52.56% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 9.71 | 17.21 | Cheaper |
Ent. to Revenue | 2.94 | 334.38 | Cheaper |
PE Ratio | 50.25 | 26.92 | Expensive |
Price to Book | 2.59 | 12.15 | Cheaper |
Dividend Yield | - | 2.77 | - |
Std. Deviation (3M) | 90.27 | 68.34 | Riskier |
Debt to Equity | -1.99 | -1.00 | Cheaper |
Debt to Assets | 1.62 | 0.48 | Expensive |
Market Cap | 693.71M | 5.31B | Emerging |